These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 19433863)

  • 1. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
    Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease.
    Targosz-Gajniak M; Siuda J; Ochudło S; Opala G
    J Neurol Sci; 2009 Aug; 283(1-2):79-82. PubMed ID: 19268974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
    Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study.
    Verdelho A; Madureira S; Moleiro C; Ferro JM; Santos CO; Erkinjuntti T; Pantoni L; Fazekas F; Visser M; Waldemar G; Wallin A; Hennerici M; Inzitari D;
    Neurology; 2010 Jul; 75(2):160-7. PubMed ID: 20625169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL.
    Viswanathan A; Gschwendtner A; Guichard JP; Buffon F; Cumurciuc R; O'Sullivan M; Holtmannspötter M; Pachai C; Bousser MG; Dichgans M; Chabriat H
    Neurology; 2007 Jul; 69(2):172-9. PubMed ID: 17620550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.
    Burns JM; Church JA; Johnson DK; Xiong C; Marcus D; Fotenos AF; Snyder AZ; Morris JC; Buckner RL
    Arch Neurol; 2005 Dec; 62(12):1870-6. PubMed ID: 16344345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
    Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
    J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer's disease with normal control comparison.
    Chang YT; Chang CC; Lin HS; Huang CW; Chang WN; Lui CC; Lee CC; Lin YT; Chen CH; Chen NC
    Acta Neurol Taiwan; 2012 Jun; 21(2):64-73. PubMed ID: 22879115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter lesions on magnetic resonance imaging and their relationship with vascular risk factors in memory clinic attenders.
    Lazarus R; Prettyman R; Cherryman G
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):274-9. PubMed ID: 15717341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
    Staekenborg SS; Gillissen F; Romkes R; Pijnenburg YA; Barkhof F; Scheltens P; van der Flier WM
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.
    Behl P; Bocti C; Swartz RH; Gao F; Sahlas DJ; Lanctot KL; Streiner DL; Black SE
    Arch Neurol; 2007 Feb; 64(2):266-72. PubMed ID: 17296844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
    Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
    Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment and diffuse white matter atrophy in alcoholics.
    Mochizuki H; Masaki T; Matsushita S; Ugawa Y; Kamakura K; Arai H; Motoyoshi K; Higuchi S
    Clin Neurophysiol; 2005 Jan; 116(1):223-8. PubMed ID: 15589200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.
    Gurol ME; Irizarry MC; Smith EE; Raju S; Diaz-Arrastia R; Bottiglieri T; Rosand J; Growdon JH; Greenberg SM
    Neurology; 2006 Jan; 66(1):23-9. PubMed ID: 16401840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period.
    Tu MC; Huang CW; Chen NC; Chang WN; Lui CC; Chen CF; Chen C; Wang YL; Lin YT; Chang CC
    Acta Neurol Taiwan; 2010 Sep; 19(3):168-77. PubMed ID: 20824536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study.
    Devine ME; Fonseca JA; Walker RW; Sikdar T; Stevens T; Walker Z
    Int J Geriatr Psychiatry; 2007 Nov; 22(11):1120-6. PubMed ID: 17457951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective cognitive failures and hippocampal volume in elderly with white matter lesions.
    van Norden AG; Fick WF; de Laat KF; van Uden IW; van Oudheusden LJ; Tendolkar I; Zwiers MP; de Leeuw FE
    Neurology; 2008 Oct; 71(15):1152-9. PubMed ID: 18838662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive status correlates with neuropathologic stage in Parkinson disease.
    Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
    Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.